PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25550798-12	2014	Both celecoxib and the combination treatment inhibited lymphangiogenesis and the expression of COX-2 and VEGF-C.	Celecoxib	5-14	vascular endothelial growth factor C	Mus musculus	105-111	
25550798-15	2014	Celecoxib and celecoxib in combination with tegafur/gimeracil/oteracil potassium possibly by reducing the expression of COX-2, in turn down-regulating the expression of VEGF-C, resulted in the inhibition of lymphangiogenesis.	Celecoxib	0-9	vascular endothelial growth factor C	Mus musculus	169-175	
25550798-15	2014	Celecoxib and celecoxib in combination with tegafur/gimeracil/oteracil potassium possibly by reducing the expression of COX-2, in turn down-regulating the expression of VEGF-C, resulted in the inhibition of lymphangiogenesis.	Celecoxib	14-23	vascular endothelial growth factor C	Mus musculus	169-175